TY - JOUR AU - Lovász, Barbara Dorottya AU - Végh, Zsuzsanna AU - Golovics, Petra Anna AU - Kiss, Lajos Sándor AU - Horváth, Ágnes AU - Szita, István AU - Pandúr, Tünde AU - Molnár, Csaba AU - Komáromi, Erzsébet AU - Mester, Gábor AU - Balogh, Mihály AU - Lakatos, László AU - Lakatos, Péter László TI - „A Crohn-betegség epidemiológiájának változásai a Veszprém megyei populációs adatbázis feldolgozása alapján” PhD doktori értekezés tézisei JF - CENTRAL EUROPEAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY / GASZTROENTEROLÓGIAI ÉS HEPATOLÓGIAI SZEMLE J2 - CENT EUR J GASTRO HEPATOL VL - 5 PY - 2019 IS - 1 SP - 31 EP - 35 PG - 5 SN - 2415-9107 DO - 10.33570/CEUJGH.5.1.31 UR - https://m2.mtmt.hu/api/publication/34441262 ID - 34441262 LA - Hungarian DB - MTMT ER - TY - JOUR AU - Dignass, A AU - Stoynov, S AU - Dorofeyev, AE AU - Grigorieva, GA AU - Tomsova, E AU - Altorjay, István AU - Tuculanu, D AU - Bunganic, I AU - Pokrotnieks, J AU - Kupcinskas, L AU - Dilger, K AU - Greinwald, R AU - Mueller, R ED - Tulassay, Zsolt / Collaborator ED - Herszényi, László / Collaborator ED - Juhász, Márk / Collaborator ED - Miheller, Pál / Collaborator ED - Mihály, Emese / Collaborator ED - Palatka, Károly / Collaborator ED - Kacska, S / Collaborator ED - Demeter, P / Collaborator ED - Penyige, J / Collaborator ED - Sike, R / Collaborator ED - Mester, Gábor / Collaborator ED - Balogh, M / Collaborator ED - Rácz, István / Collaborator ED - Szabó, A / Collaborator ED - Karasz, T / Collaborator ED - Csöndes, M / Collaborator TI - Once versus three times daily dosing of oral budesonide for active Crohn's disease: a double-blind, double-dummy, randomised trial JF - JOURNAL OF CROHNS & COLITIS J2 - J CROHNS COLITIS VL - 8 PY - 2014 IS - 9 SP - 970 EP - 980 PG - 11 SN - 1873-9946 DO - 10.1016/j.crohns.2014.01.021 UR - https://m2.mtmt.hu/api/publication/2808988 ID - 2808988 AB - BACKGROUND: Oral budesonide 9 mg/day represents first-line treatment of mild-to-moderately active ileocolonic Crohn's disease. However, there is no precise recommendation for budesonide dosing due to lack of comparative data. A once-daily (OD) 9 mg dose may improve adherence and thereby efficacy. METHODS: An eight-week, double-blind, double-dummy randomised trial compared budesonide 9 mg OD versus 3mg three-times daily (TID) in patients with mild-to-moderately active ileocolonic Crohn's disease. Primary endpoint was clinical remission defined as CDAI <150 at week 8 (last observation carried forward). RESULTS: The final intent-to-treat population comprised 471 patients (238 [9 mg OD], 233 [3 mg TID]). The confirmatory population for the primary endpoint analysis was the interim per protocol population (n=377; 188 [9 mg OD], 189 [3mg TID]), in which the primary endpoint was statistically non-inferior with budesonide 9 mg OD versus 3 mg TID. Clinical remission was achieved in 71.3% versus 75.1%, a difference of -3.9% (95% CI [-14.6%; 6.4%]; p=0.020 for non-inferiority). The mean (SD) time to remission was 21.9 (13.8) days versus 21.4 (14.6) days with budesonide 9 mg OD versus 3 mg TID, respectively. In a subpopulation of 122 patients with baseline SES-CD ulcer score >/=1, complete mucosal healing occurred in 32.8% (21/64) on 9 mg OD and 41.4% (24/58) on 3mg TID; deep remission (mucosal healing and clinical remission) was observed in 26.6% (17/64) and 32.8% (19/58) of patients, respectively. Treatment-emergent suspected adverse drug reactions were reported in 4.6% of 9 mg OD and 4.7% of 3 mg TID patients. CONCLUSIONS: Budesonide at the recommended dose of 9 mg/day can be administered OD without impaired efficacy and safety compared to 3mg TID dosing in mild-to-moderately active Crohn's disease. LA - English DB - MTMT ER - TY - JOUR AU - Lakatos, Péter László AU - Lovász, Barbara Dorottya AU - David, G AU - Pandur, T AU - Erdelyi, Z AU - Mester, Gábor AU - Balogh, M AU - Szipocs, I AU - Molnar, C AU - Komaromi, E AU - Golovics, Petra Anna AU - Végh, Zsuzsanna AU - Mandel, M AU - Horvath, A AU - Szathmári, Miklós AU - Kiss, Lajos Sándor AU - Lakatos, László TI - The risk of lymphoma and immunomodulators in patients with inflammatory bowel diseases. Results from a population-based cohort in Eastern Europe TS - Results from a population-based cohort in Eastern Europe JF - JOURNAL OF CROHNS & COLITIS J2 - J CROHNS COLITIS VL - 7 PY - 2013 IS - 5 SP - 385 EP - 391 PG - 7 SN - 1873-9946 DO - 10.1016/j.crohns.2012.06.011 UR - https://m2.mtmt.hu/api/publication/1984310 ID - 1984310 N1 - 1st Department of Medicine, Semmelweis University, Budapest, Hungary Department of Medicine, Csolnoky F. Province Hospital, Veszprem, Hungary Department of Medicine, Grof Eszterhazy Hospital, Papa, Hungary Department of Medicine, Municipal Hospital, Tapolca, Hungary Department of Infectious Diseases, Magyar Imre Hospital, Ajka, Hungary Dept. of Gastroenterology Municipal Hospital, Varpalota, Hungary Department of Pediatrics, Csolnoky F. Province Hospital, Veszprem, Hungary Cited By :16 Export Date: 6 October 2020 Correspondence Address: Lakatos, P.L.; 1st Department of Medicine, Semmelweis University, Koranyi S. utca 2/A, H-1083, Hungary; email: lakatos.peter_laszlo@med.semmelweis-univ.hu Chemicals/CAS: azathioprine, 446-86-6; Antibodies, Monoclonal; Azathioprine, 446-86-6; Immunosuppressive Agents; Tumor Necrosis Factor-alpha; infliximab 1st Department of Medicine, Semmelweis University, Budapest, Hungary Department of Medicine, Csolnoky F. Province Hospital, Veszprem, Hungary Department of Medicine, Grof Eszterhazy Hospital, Papa, Hungary Department of Medicine, Municipal Hospital, Tapolca, Hungary Department of Infectious Diseases, Magyar Imre Hospital, Ajka, Hungary Dept. of Gastroenterology Municipal Hospital, Varpalota, Hungary Department of Pediatrics, Csolnoky F. Province Hospital, Veszprem, Hungary Cited By :16 Export Date: 15 October 2020 Correspondence Address: Lakatos, P.L.; 1st Department of Medicine, Semmelweis University, Koranyi S. utca 2/A, H-1083, Hungary; email: lakatos.peter_laszlo@med.semmelweis-univ.hu Chemicals/CAS: azathioprine, 446-86-6; Antibodies, Monoclonal; Azathioprine, 446-86-6; Immunosuppressive Agents; Tumor Necrosis Factor-alpha; infliximab 1st Department of Medicine, Semmelweis University, Budapest, Hungary Department of Medicine, Csolnoky F. Province Hospital, Veszprem, Hungary Department of Medicine, Grof Eszterhazy Hospital, Papa, Hungary Department of Medicine, Municipal Hospital, Tapolca, Hungary Department of Infectious Diseases, Magyar Imre Hospital, Ajka, Hungary Dept. of Gastroenterology Municipal Hospital, Varpalota, Hungary Department of Pediatrics, Csolnoky F. Province Hospital, Veszprem, Hungary Cited By :18 Export Date: 3 July 2021 Correspondence Address: Lakatos, P.L.; 1st Department of Medicine, Koranyi S. utca 2/A, H-1083, Hungary; email: lakatos.peter_laszlo@med.semmelweis-univ.hu LA - English DB - MTMT ER - TY - JOUR AU - Lakatos, Péter László AU - Végh, Zsuzsanna AU - Lovász, Barbara Dorottya AU - David, G AU - Pandur, T AU - Erdelyi, Z AU - Szita, I AU - Mester, Gábor AU - Balogh, M AU - Szipocs, I AU - Molnar, C AU - Komaromi, E AU - Golovics, Petra Anna AU - Mandel, M AU - Horvath, A AU - Szathmári, Miklós AU - Kiss, Lajos Sándor AU - Lakatos, László TI - Is current smoking still an important environmental factor in inflammatory bowel diseases? Results from a population-based incident cohort JF - INFLAMMATORY BOWEL DISEASES J2 - INFLAMM BOWEL DIS VL - 19 PY - 2013 IS - 5 SP - 1010 EP - 1017 PG - 8 SN - 1078-0998 DO - 10.1097/MIB.0b013e3182802b3e UR - https://m2.mtmt.hu/api/publication/2019128 ID - 2019128 N1 - Department of Medicine, Semmelweis University, Budapest, Hungary Department of Medicine, Csolnoky F. Province Hospital, Veszprem, Hungary Department of Medicine, Grof Eszterhazy Hospital, Papa, Hungary Department of Medicine, Municipal Hospital, Tapolca, Hungary Department of Infectious Diseases, Magyar Imre Hospital, Ajka, Hungary Department of Gastroenterology, Municipal Hospital, Varpalota, Hungary Department of Pediatrics, Csolnoky F. Province Hospital, Veszprem, Hungary Cited By :59 Export Date: 3 July 2021 CODEN: IBDNB Correspondence Address: Lakatos, P.L.; Department of Medicine, , Budapest, Hungary LA - English DB - MTMT ER - TY - JOUR AU - Lovász, Barbara Dorottya AU - Lakatos, László AU - Horvath, A AU - Szita, I AU - Pandur, T AU - Mandel, M AU - Végh, Zsuzsanna AU - Golovics, Petra Anna AU - Mester, Gábor AU - Balogh, M AU - Molnar, C AU - Komaromi, E AU - Kiss, Lajos Sándor AU - Lakatos, Péter László TI - Evolution of disease phenotype in adult and pediatric onset Crohn’s disease in a population-based cohort. JF - WORLD JOURNAL OF GASTROENTEROLOGY J2 - WORLD J LGASTROENTEROL VL - 19 PY - 2013 IS - 14 SP - 2217 EP - 2226 PG - 10 SN - 1007-9327 DO - 10.3748/wjg.v19.i14.2217 UR - https://m2.mtmt.hu/api/publication/2241564 ID - 2241564 LA - English DB - MTMT ER - TY - JOUR AU - Lovász, Barbara Dorottya AU - Lakatos, László AU - Golovics, Petra Anna AU - David, G AU - Pandur, T AU - Erdelyi, Z AU - Mester, Gábor AU - Balogh, M AU - Szita, I AU - Molnar, C AU - Komaromi, E AU - Végh, Zsuzsanna AU - Mandel, M AU - Kiss, Lajos Sándor AU - Lakatos, Péter László TI - Risk of colorectal cancer in CD patients with colonic involvement and stenosing disease 1977-2012. Results from a population-based study JF - UNITED EUROPEAN GASTROENTEROLOGY JOURNAL J2 - UEG JOURNAL VL - 1 PY - 2013 IS - Suppl. 1 SP - A206 SN - 2050-6406 UR - https://m2.mtmt.hu/api/publication/2441544 ID - 2441544 LA - English DB - MTMT ER - TY - JOUR AU - Döbrönte, Zoltán AU - Szenes, M AU - Gasztonyi, Beáta AU - Csermely, L AU - Kovács, M AU - Lakatos, László AU - Mester, Gábor AU - Pandur, T AU - Patai, Árpád AU - Pák, P AU - Pécsi, G AU - Rácz, István AU - Sarang, K AU - Stöckert, A AU - Székely, A Varga Szabó L AU - Salamonné Toldy, Erzsébet TI - Role of pulseoximetry monitoring during gastrointestinal endoscopy with sedoanalgesic premedication JF - ZEITSCHRIFT FÜR GASTROENTEROLOGIE J2 - Z GASTROENTEROL VL - 51 PY - 2013 IS - 5 PG - 1 SN - 0044-2771 DO - 10.1055/s-0033-1347464 UR - https://m2.mtmt.hu/api/publication/2470290 ID - 2470290 LA - English DB - MTMT ER - TY - JOUR AU - Lovász, Barbara Dorottya AU - Lakatos, László AU - Golovics, Petra Anna AU - David, G AU - Pandur, T AU - Erdelyi, Z AU - Mester, Gábor AU - Balogh, M AU - Szita, I AU - Molnar, C AU - Komaromi, E AU - Végh, Zsuzsanna AU - Mandel, M AU - Kiss, L AU - Lakatos, Péter László TI - Risk of colorectal cancer in CD patients with colonic involvement and stenosing disease. 1977 – 2012. Results from a population-based study JF - ZEITSCHRIFT FÜR GASTROENTEROLOGIE J2 - Z GASTROENTEROL VL - 51 PY - 2013 SP - A41 SN - 0044-2771 UR - https://m2.mtmt.hu/api/publication/2593465 ID - 2593465 N1 - # Cikk azonosító vagy Doi Azonosító érték vagy Kezdő oldal nem található: A41 LA - English DB - MTMT ER - TY - JOUR AU - Golovics, Petra Anna AU - Mandel, M AU - Lakatos, László AU - Lovász, Barbara Dorottya AU - Végh, Zsuzsanna AU - Szita, I AU - Mester, Gábor AU - Balogh, M AU - Molnár, C AU - Komáromi, E AU - Mohás, A AU - Szilágyi, Blanka Krisztina AU - Fekete, S AU - Kiss, L AU - Lakatos, Péter László TI - Prevalence and predictors of hospitalization and re-hospitalization in Crohn's disease in a population based inception cohort between 2000 – 2012 JF - ZEITSCHRIFT FÜR GASTROENTEROLOGIE J2 - Z GASTROENTEROL VL - 51 PY - 2013 SP - A20 SN - 0044-2771 UR - https://m2.mtmt.hu/api/publication/2593466 ID - 2593466 LA - English DB - MTMT ER - TY - JOUR AU - Döbrönte, Zoltán AU - Szenes, M AU - Gasztonyi, Beáta AU - Csermely, L AU - Kovács, M AU - Lakatos, László AU - Lakner, L AU - Mester, Gábor AU - Pandur, T AU - Patai, Árpád AU - Pák, P AU - Pécsi, Gy AU - Rácz, István AU - Sarang, K AU - Ströckert, A AU - Székely, A AU - Varga, Szabó L TI - Az endoszkópos vizsgálatok pulzoximetriás monitorizálásának jelentőse. Az MTA VEAB Gasztroenterológiai Munkabizottságának prospektív multicentrikus vizsgálata TS - Az MTA VEAB Gasztroenterológiai Munkabizottságának prospektív multicentrikus vizsgálata JF - ORVOSI HETILAP J2 - ORV HETIL VL - 154 PY - 2013 SP - 825 EP - 833 PG - 9 SN - 0030-6002 DO - 10.1556/OH.2013.29613 UR - https://m2.mtmt.hu/api/publication/2827474 ID - 2827474 LA - Hungarian DB - MTMT ER -